Holen Sie sich die Stockscreener-App
2.33
1.30%
0.03
Handel nachbörslich:
2.33
Schlusskurs vom Vortag:
$2.30
Offen:
$2.3
24-Stunden-Volumen:
463.15K
Relative Volume:
1.61
Marktkapitalisierung:
$64.95M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.14M
KGV:
-2.5326
EPS:
-0.92
Netto-Cashflow:
$-12.64M
1W Leistung:
-10.21%
1M Leistung:
-12.08%
6M Leistung:
+17.09%
1J Leistung:
+25.27%
1-Tages-Spanne:
$2.29
$2.50
1-Wochen-Bereich:
$2.2427
$2.67
52-Wochen-Spanne:
$1.26
$3.12
Immix Biopharma Inc Stock (IMMX) Company Profile
Firmenname
Immix Biopharma Inc
Sektor
Branche
Telefon
(888) 958-1084
Adresse
11400 WEST OLYMPIC BLVD., LOS ANGELES
Vergleichen Sie IMMX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMMX
Immix Biopharma Inc
|
2.33 | 64.68M | 0 | -14.14M | -12.64M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Immix Biopharma Inc Aktie (IMMX) Neueste Nachrichten
Is Immix Biopharma Inc. building a consolidation base2025 Year in Review & Stock Timing and Entry Methods - Newser
Immix Biopharma Inc. stock prediction for this weekDividend Hike & Daily Volume Surge Trade Alerts - Newser
Is Immix Biopharma Inc. stock bottoming outRecession Risk & Safe Entry Trade Signal Reports - Newser
Sector ETF performance correlation with Immix Biopharma Inc.Weekly Stock Recap & Low Drawdown Momentum Ideas - Newser
What high frequency data says about Immix Biopharma Inc.July 2025 Market Mood & Safe Swing Trade Setups - Newser
How moving averages guide Immix Biopharma Inc. tradingWeekly Stock Report & Community Consensus Stock Picks - Newser
Can Traders Expect Breakout From Immix Biopharma Inc. This WeekQuarterly Performance Summary & AI Enhanced Execution Alerts - 선데이타임즈
Quantitative breakdown of Immix Biopharma Inc. recent moveConservative Investment Setup and Risk Analysis - Newser
Relative strength of Immix Biopharma Inc. in sector analysisFree Alpha Focused Technical Trade Signals - Newser
How to forecast Immix Biopharma Inc. trends using time seriesSwing Trade Planning with Consistent Setup - Newser
Market reaction to Immix Biopharma Inc.’s recent newsTrading Volume Spike and Reversal Analysis - Newser
Machine Learning Models Forecast Immix Biopharma Inc. UptickCapital Efficiency Optimized Stock Alerts Reviewed - beatles.ru
Visual analytics tools that track Immix Biopharma Inc. performanceEarnings Report Summary with Market Impact - Newser
Live market analysis of Immix Biopharma Inc.Equity Portfolio Outlook and Performance Summary - Newser
Breakout Traders Target Immix Biopharma Inc. on Recovery SetupIntraday Trend Analysis for Fast Gains Released - metal.it
Real time social sentiment graph for Immix Biopharma Inc.Buy Zone Strategy with Pattern Recognition - Newser
Can machine learning forecast Immix Biopharma Inc. recoveryAI Generated Buy/Sell Signal Forecast - Newser
Is Immix Biopharma Inc. trending in predictive chart modelsFree Conservative Entry for High Return Setup - Newser
Immix Biopharma Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
Immix Biopharma, Inc. SEC 10-Q Report - TradingView
Immix Biopharma: Insider Transactions and Ownership Amid Recent Market Value Drop - AInvest
Immix Biopharma Loses US$9.2m Market Value But Insiders See Windfall Of US$19k - Yahoo Finance
Immix Biopharma : Presentation (IMMX Corporate presentation August 2025) - MarketScreener
ImmixBio plans to partner out CAR-T therapy for other diseases By Investing.com - Investing.com South Africa
ImmixBio plans to partner out CAR-T therapy for other diseases - Investing.com
Immix Biopharma plans to partner-out other serious disease programs - MarketScreener
Immix Biopharma Announces Other Serious Diseases Strategy - GlobeNewswire
Immix Biopharma Unveils Strategy to Tackle Other Serious Diseases with NXC-201 CAR-T Therapy, Plans to Partner-Out Programs and Seek BLA Approval for AL Amyloidosis Treatment - AInvest
Immix Biopharma's Game-Changing CAR-T Therapy Eyes Multiple Disease Markets Through Strategic Partnerships - Stock Titan
Pricing Power vs. Volume Pressure: What's Driving PepsiCo Now? - The Globe and Mail
Real time alert setup for Immix Biopharma Inc. performanceFree News Based Entry Opportunity Alerts - Newser
Finanzdaten der Immix Biopharma Inc-Aktie (IMMX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Immix Biopharma Inc-Aktie (IMMX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Morris Gabriel S | CFO |
Jun 18 '25 |
Buy |
2.28 |
2,225 |
5,071 |
288,059 |
| Hsu Jason | Director |
Dec 23 '24 |
Buy |
2.19 |
40,000 |
87,680 |
893,000 |
| Hsu Jason | Director |
Dec 20 '24 |
Buy |
2.17 |
7,700 |
16,678 |
853,000 |
| Hsu Jason | Director |
Aug 21 '24 |
Buy |
2.23 |
15,000 |
33,390 |
837,200 |
| Hsu Jason | Director |
Aug 22 '24 |
Buy |
2.25 |
8,100 |
18,233 |
845,300 |
| Ng Carey | Director |
Aug 16 '24 |
Buy |
1.86 |
10,000 |
18,600 |
20,000 |
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):